| A1:2 | noradrenergic cell groups |
| ACTH | adrenocorticotropic hormone |
| Adr | adrenaline |
| Amb | ambigous nucleus |
| AMY | amygdala |
| AP | area postrema |
| ARC | arcuate nucleus |
| AV3V | anteroventral periventricular area |
| AVP | arginine vasopressin |
| AVPV | rostral periventricular region of the third ventricle |
| BDNF | brain-derived neurotrophic factor |
| BNST | bed nucleus of the stria terminalis |
| C1, 2 | adrenergic cell groups |
| CNS | central nervous system |
| CORT | glucocorticoids: in humans, cortisol; in rodents, corticosterone |
| CPP | conditioned place preference |
| CRH | corticotropin-releasing hormone |
| CXCR4 | C-X-C chemokine receptor type 4 receptor |
| DMN | dorsomedial hypothalamic nucleus |
| DMX | dorsal motor nucleus of the vagus nerve (nerve X) |
| DREADDs | designer receptors exclusively activated by designer drugs |
| ERK | extracellular signal-regulated kinase ½ |
| FSH | folliculus-stimulating hormone |
| GABA | gamma-amonibutyric acid |
| GAD | glutamic acid decarboxylase |
| GFP | green fluorescent protein |
| GnIH | gonadotropin inhibitory hormone |
| GnRH | gonadotropin-releasing hormone |
| GPCR | G-protein coupled receptor |
| GRP | gastrin-releasing peptide |
| HC | hippocampus |
| HPA | hypothalamic–pituitary–adrenocortical axis |
| HPG | hypothalamic–pituitary–gonadal axis |
| HTH | hypothalamus |
| ICV | intracerebroventricularly |
| IHC | immunohistochemistry |
| IML | intermediolateral cell column of the spinal cord |
| IR | immunoreactivity |
| ISH | in situ hybridization |
| IT | intrathecally |
| KISS1R | kisspeptin receptor |
| KNDy | neurons coexpressing kisspeptin, neurokinin B, and dynorphin |
| KO | knockout |
| KP | kisspeptin |
| LC | locus coeruleus |
| LH | luteinizing hormone |
| LHA | lateral hypothalamic area |
| LPXRFamide | leucine(L)–proline(P)–X-RFamide |
| MAPK | mitogen-activated protein kinase |
| MCH | melanin-concentrating hormone |
| NA | noradrenaline |
| NK | neurokinin |
| NPAF | neuropeptide AF |
| NPFF | neuropeptide FF |
| NPFFR | neuropeptide FF receptor |
| NPSF | neuropeptide SF |
| NPVF | neuropeptide VF, the human equivalent of RFRP-3 |
| NPY | neuropeptide Y |
| NTS | nucleus of the solitary tract |
| NUCB2 | nucleobindin-2 protein |
| OVX | ovariectomized |
| PACAP | pituitary adenylate cyclase-activating polypeptide |
| PAG | periaqueductal gray matter |
| PeN | periventricular hypothalamic nucleus |
| PFC | prefrontal cortex |
| POA | preoptic area of the hypothalamus |
| POMC | pro-opio–melanocortin |
| PRL | prolactin |
| PrRP | prolactin-releasing peptide |
| PrRPR/PRLHR | PrRP receptor |
| PTSD | post-traumatic stress disorder |
| PVN | paraventricular hypothalamic nucleus |
| QRFP | pyroglutamylated RFamide peptide/QRFP receptor |
| QRFPR | QRFP receptor |
| RFRP | RFamide-related peptide/RFRP receptor |
| RFRPR | RFRP receptor |
| RT-PCR | reverse transcriptase polymerase chain reaction |
| SAM | sympathoadrenomedullary system |
| SON | supraoptic nucleus |
| TH | tyrosine hydroxylase |
| VGAT | vesicular GABA transporter |
| VGLUT | vesicular glutamate transporter |
| VMN | ventromedial hypothalamic nucleus |